Evercore ISI analyst Elizabeth Anderson raised the firm’s price target on Fortrea (FTRE) to $14 from $11 and keeps an In Line rating on the shares. The company’s transition under new leadership is off to a promising start as the Q3 book-to-bill ratio held steady despite management changes, reflecting both internal focus and an improving demand landscape, the analyst tells investors in a research note. The firm added that while the stock’s rapid quarter-to-date rise keeps it cautious, the market’s potential improvement into 2026 could prompt a re-evaluation.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FTRE:
- Fortrea Holdings Reports Q3 2025 Earnings and Raises Guidance
- Fortrea Holdings Inc. Navigates Growth and Challenges in Q3 Earnings Call
- Fortrea raises FY25 revenue view to $2.700B-$2.750B from $2.600-$2.700
- Fortrea reports Q3 adjusted EPS 12c, consensus 16c
- Fortrea and GE Healthcare’s New Diagnostic Study: A Potential Game-Changer in Cancer Detection